Table 1: Baseline characteristics for included patients.
|
|
5-ALA (N = 52) |
White light (N = 37) |
|
Age |
|
|
|
Median (range) |
61 (25-81) |
68 (47-82) |
|
≤ 55 |
16 (31%) |
7 (19%) |
|
> 55 |
36 (69%) |
30 (81%) |
|
Sex |
|
|
|
Male |
27 (52%) |
22 (59%) |
|
Female |
25 (48%) |
15 (41%) |
|
Pathological analysis |
|
|
|
Glioblastoma multiforme (WHO IV) |
47 (90%) |
35 (95%) |
|
Gliosarcoma (WHO IV) |
0 |
2 (5%) |
|
Astrocytoma (WHO IV) |
2 (4%) |
0 |
|
Anaplastic oligodendroglioma (WHO III) |
1 (2%) |
0 |
|
Angioplastic oligodendroglioma (WHO III) |
1 (2%) |
0 |
|
Anaplastic astrocytoma (WHO III) |
1 (2%) |
0 |